h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
How-To Videos
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
NCCDFWi001-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
iPSC Line
hPSCreg name
NCCDFWi001-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
NCCDFWi001-A (RRID:CVCL_YM45)
iPSC line type
Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines
No similar lines found.
Last update
19th December 2019
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
National Center for Cardiovascular Diseases & Fuwai Hospital (NCCDFW)
External iPSC Databases
Cellosaurus
CVCL_YM45
Wikidata
Q95992665
General iPSC Information
Publications
Ma B et al. Generation of a human induced pluripotent stem cell line (NCCDFWi001-A) from a Marfan syndrome patient carrying two FBN1 variants (c.2613A > C and c.684_736 + 4del). Stem cell research. 2020 Jan;42:101690.
Iosef C et al. Quantitative proteomics reveal lineage-specific protein profiles in iPSC-derived Marfan syndrome smooth muscle cells. Scientific reports. 2020 Nov 23;10(1):20392.
Li T et al. Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene. Stem cell research. 2021 Oct;56:102543.
Mansfield C et al. Translational potential of hiPSCs in predictive modeling of heart development and disease. Birth defects research. 2022 Oct 1;114(16):926-947.
Aalders J et al. Human stem cell models for Marfan syndrome: a brief overview of the rising star in disease modelling. Frontiers in cell and developmental biology. 2024;12:1498669.
Feng Xiaoying et al. Therapeutic Opportunities of Marfan Syndrome: Current Perspectives. Drug Design, Development and Therapy. 2025-08-00.
Mohammadi Amirhossein et al. Genetic engineering frontiers in cell manipulation-based tissue engineering: A comprehensive review. BioImpacts. 2025-11-04.
Abdul-Rahman Toufik et al. Gene editing for inherited cardiac conditions: A new frontier in cardiology. Trends in Cardiovascular Medicine. 2026-05-00.
Subclones
NCCDFWi001-A-1
iPSC Derivation
General
Login to share your feedback, experiences or results with the research community.